Brad Nelson

Brad Nelson is a prominent figure in the field of immunotherapy and medical genetics, currently serving as Co-founder and CEO of Innovakine Therapeutics Inc. since August 2019. Brad holds the position of President at Victory Immunotherapy Consulting Inc. since January 2017, and has been the Scientific Co-director for the Immunotherapy Program at BC Cancer since January 2014. Additionally, Brad is a Professor of Medical Genetics at The University of British Columbia and has maintained a role as Director and Distinguished Scientist at the Deeley Research Centre within the BC Cancer Agency since July 2003. Furthermore, Brad is a Professor of Biochemistry and Microbiology at the University of Victoria, also since July 2003. Educationally, Brad earned a PhD in Molecular and Cellular Biology from the University of California, Berkeley, between 1987 and 1991.